| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |